These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29073938)

  • 1. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.
    Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L
    Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1.
    Huang P; Xi J; Liu S
    Biomed Pharmacother; 2016 Oct; 83():850-856. PubMed ID: 27505862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Li X; Zhou Q; Tao L; Yu C
    Oncol Rep; 2017 Sep; 38(3):1774-1782. PubMed ID: 28731196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.
    Zhang L; Liu SK; Song L; Yao HR
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):556-564. PubMed ID: 30831032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
    Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.
    Dong P; Xiong Y; Watari H; Hanley SJ; Konno Y; Ihira K; Suzuki F; Yamada T; Kudo M; Yue J; Sakuragi N
    Sci Rep; 2016 Oct; 6():35480. PubMed ID: 27765948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
    Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
    Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-10b Downregulated by DNA Methylation Acts as a Tumor Suppressor in HPV-Positive Cervical Cancer via Targeting Tiam1.
    Yu M; Xu Y; Pan L; Feng Y; Luo K; Mu Q; Luo G
    Cell Physiol Biochem; 2018; 51(4):1763-1777. PubMed ID: 30504727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.
    Xu D; Dong P; Xiong Y; Yue J; Konno Y; Ihira K; Kobayashi N; Todo Y; Watari H
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas.
    Liu X; Yang WT; Zheng PS
    Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.
    Wu F; Zhou J
    BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
    Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
    Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.